JSW Infrastructure Reports Strong Q1 FY27 Performance with 18% Revenue Growth; Expands Capacity and Strengthens Growth Pipeline 22/07/2026 / Financial Results / Quarterly Financial Results JSW Infrastructure Reports Strong Q1 FY27 Performance with 18% Revenue Growth; Expands Capacity and Strengthens Growth Pipeline Read Post »
Aurobindo Pharma Subsidiary Receives ANVISA Approval for Biosimilars Manufacturing Facility in Brazil 21/07/2026 / Regulatory Filings / Regulatory Approval Aurobindo Pharma Subsidiary Receives ANVISA Approval for Biosimilars Manufacturing Facility in Brazil Read Post »
Bandhan Bank Reports 34.9% YoY Growth in Q1 FY27 Profit as Asset Quality Improves and Loan Book Expands 21/07/2026 / Financial Results / Quarterly Financial Results Bandhan Bank Reports 34.9% YoY Growth in Q1 FY27 Profit as Asset Quality Improves and Loan Book Expands Read Post »
JSW Infrastructure Reports 18% Revenue Growth in Q1 FY27; Strengthens Logistics Expansion and Balance Sheet 21/07/2026 / Financial Results / Quarterly Financial Results JSW Infrastructure Reports 18% Revenue Growth in Q1 FY27; Strengthens Logistics Expansion and Balance Sheet Read Post »
NIIT Reports 14% Revenue Growth in Q1 FY27; PAT Surges 85% on Strong AI-Led Demand 21/07/2026 / Financial Results / Quarterly Financial Results NIIT Reports 14% Revenue Growth in Q1 FY27; PAT Surges 85% on Strong AI-Led Demand Read Post »
SBI Funds Management Marks Historic Stock Market Debut Following Successful IPO Listing 21/07/2026 / Business Updates / IPO Update SBI Funds Management Marks Historic Stock Market Debut Following Successful IPO Listing Read Post »
Vedanta Oil & Gas Receives Delhi High Court Notice in ONGC Arbitration Enforcement Matter 21/07/2026 / Regulatory Filings / Legal Dispute Vedanta Oil & Gas Receives Delhi High Court Notice in ONGC Arbitration Enforcement Matter Read Post »
Mahindra Finance Reports Strong Q1 FY27 with 70% PAT Growth; Disbursements Hit Record High 21/07/2026 / Financial Results / Quarterly Financial Results Mahindra Finance Reports Strong Q1 FY27 with 70% PAT Growth; Disbursements Hit Record High Read Post »
Anthem Biosciences Q1 FY27 Results: PAT at ₹1,199 Mn, EBITDA Margin Improves to 39.6% 21/07/2026 / Financial Results / Quarterly Financial Results Anthem Biosciences Q1 FY27 Results: PAT at ₹1,199 Mn, EBITDA Margin Improves to 39.6% Read Post »
IndiaMART Reports Strong Q1 FY27 Results with 10% Revenue Growth and 16% Rise in Net Profit 21/07/2026 / Financial Results / Quarterly Financial Results IndiaMART Reports Strong Q1 FY27 Results with 10% Revenue Growth and 16% Rise in Net Profit Read Post »
